Overview

Fesoterodine "add-on" Male Overactive Bladder Study

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of fesoterodine on overactive bladder symptom improvement when added to ongoing alpha blocker treatment.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Fesoterodine